Measuring lung function as a primary or secondary outcome in a clinical trial can be problematic secondary to factors that affect variability other than a physiologic response in the subject. In lung function testing variability can be subdivided into three major categories; the subject, the testing environment including the device, and the testing personnel. The Clinical and Laboratory Standards Institute, an internationally recognized organization that writes standards and guidelines for laboratory medicine published a guideline that integrated the International Organization for Standardization (ISO) quality systems model into a laboratory/healthcare practice model several years ago. We will define the model and its application in spirometry testing and how integration of the quality system model into your lung function protocol can help reduce variability.
- Describe the Clinical Laboratory Standards Institute’s Quality System Model
- Define the path of workflow and the points of variability/error that occur at each stage in spirometry testing
- Understand mechanisms to reduce variability in lung function testing
Don't wait to register for the Reducing Variability in Spirometry Testing for Clinical Trials. You'll meet influential people and maximize your opportunities for success. Start now by accessing the information below.
|Conference/Event Dates:||03/29/2016 - 03/29/2016|
|Primary Industry:||Clinical Pharmacology|
|Other Industries:||Clinical Pharmacology, Professional Healthcare|
|Audience:||This webinar will benefit medical and non-medical professionals in the biopharmaceutical industry, especially those supporting Asthma, COPD and other Respiratory drug development with roles in:
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.